We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+1.76%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$21.4B
AUM Growth
+$1.5B
Cap. Flow
+$1.66B
Cap. Flow %
7.75%
Top 10 Hldgs %
50.4%
Holding
201
New
31
Increased
27
Reduced
32
Closed
37

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$1.41B
2
CHTR icon
Charter Communications
CHTR
+$462M
3
CBRE icon
CBRE Group
CBRE
+$375M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$314M
5
VMW
VMware, Inc
VMW
+$285M

Top Sells

Rank Stock Value
1
EFX icon
Equifax
EFX
+$249M
2
IQV icon
IQVIA
IQV
+$239M
3
BIIB icon
Biogen
BIIB
+$172M
4
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$130M
5
TMO icon
Thermo Fisher Scientific
TMO
+$105M

Sector Composition

Rank Sector Weight
1 Healthcare 31.13%
2 Technology 23.99%
3 Financials 9.09%
4 Communication Services 6.05%
5 Industrials 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FRXB.WS
151
DELISTED
Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FRXB.WS
$5.25K ﹤0.01%
250,000
– –
EQRXW
152
DELISTED
EQRx, Inc. Warrant
EQRXW
$4.82K ﹤0.01%
120,085
-1,140
-0.9% -$117
SLAMW
153
DELISTED
Slam Corp. warrant
SLAMW
$2.21K ﹤0.01%
17,627
– –
GETR.WS
154
DELISTED
Getaround, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
GETR.WS
$1.56K ﹤0.01%
80,000
– –
ALVO icon
155
Alvotech
ALVO
$1.5B
– –
-437,110
Closed -$3.38M
ARGX icon
156
argenx
ARGX
$65B
– –
-161,000
Closed -$62.7M
ARWR icon
157
Arrowhead Research
ARWR
$12.3B
– –
-5,800
Closed -$207K
BIIB icon
158
Biogen
BIIB
$32B
– –
-604,098
Closed -$172M
BRKR icon
159
Bruker
BRKR
$9.07B
– –
-150,476
Closed -$11.1M
EFX icon
160
Equifax
EFX
$22.6B
– –
-1,058,697
Closed -$249M
EXAS
161
DELISTED
Exact Sciences
EXAS
– –
-602,000
Closed -$56.5M
ICE icon
162
Intercontinental Exchange
ICE
$90.5B
– –
-12,786
Closed -$1.45M
NTLA icon
163
Intellia Therapeutics
NTLA
$1.8B
– –
-116,000
Closed -$4.73M
PRVA icon
164
Privia Health
PRVA
$2.7B
– –
-74,000
Closed -$1.93M
TSEM icon
165
Tower Semiconductor
TSEM
$25.2B
– –
-1,160,000
Closed -$43.5M
UTHR icon
166
United Therapeutics
UTHR
$22B
– –
-193,267
Closed -$42.7M
TECX
167
Tectonic Therapeutic
TECX
$736M
– –
-74,975
Closed -$855K
CITE
168
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
– –
-350,000
Closed -$3.73M
KCGI
169
DELISTED
Kensington Capital Acquisition Corp. V
KCGI
– –
-775,200
Closed -$8.19M
AEL
170
DELISTED
American Equity Investment Life Holding Company
AEL
– –
-383,000
Closed -$20M
BTTX
171
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
– –
-330,619
Closed -$357K
AMAM
172
DELISTED
Ambrx Biopharma Inc
AMAM
– –
-2,269,000
Closed -$37.3M
FSRX
173
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
– –
-400,000
Closed -$4.09M
SYNH
174
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-3,075,000
Closed -$130M
RETA
175
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-451,700
Closed -$46.1M
4 5 6
7
8

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q3 2023 Portfolio in Review

As of Q3 2023, Thomas Steyer held 201 positions worth $21.4B, up 7.5% from $19.9B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Thomas Steyer deployed $1.66B of net new capital in Q3 2023, opening 31 new positions and adding to 27 existing holdings. Its largest new stake was Charter Communications: 1,111,341 shares worth $489M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was IQVIA, an estimated $239M trimmed.

  • Thomas Steyer's largest Q3 2023 buy was Charter Communications: 1,111,341 shares worth $489M.
  • Thomas Steyer added most to Activision Blizzard in Q3 2023, an estimated $1.41B increase.
  • Thomas Steyer's biggest Q3 2023 reduction was IQVIA, cutting an estimated $239M.
  • Thomas Steyer fully exited Equifax in Q3 2023, selling an estimated $249M.
  • Thomas Steyer's ten largest holdings make up 50% of its $21.4B portfolio in Q3 2023.
  • Thomas Steyer opened 31 new positions and closed 37 in Q3 2023.
  • Thomas Steyer's portfolio value rose 7.5% quarter-over-quarter to $21.4B.

Based on Farallon Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.